TABLE 33.3.
Subtype | Typical Location | Histologic Architecture | Cellular Features | Immunophenotype |
---|---|---|---|---|
Diffuse large B-cell (DLBCL) | Usually multicentric lymphadenopathy | Diffuse | Large cells; round nuclei; one (central) or multiple nucleoli; high mitotic rate; “starry sky” appearance | CD1+, CD20+, CD21+, CD45+, CD79a+, Pax5+, MHCII+, CD18low |
Peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS) | Usually multicentric lymphadenopathy | Diffuse | Variable size (small to large); irregular nuclei, variable chromatin, prominent nucleoli; varied mitotic activity | CD3+, CD79a–, CD21–, CD45+, CD5+, CD4+/–, CD8+/–, CD18high, TCRαβ |
Marginal zone lymphoma (MZL) | Nodal (nMZL) or splenic (sMZL) or extranodal mucosal | Nodular/ follicular | Mostly intermediate- sized cells- abundant pale cytoplasm; irregular nuclei with peripheralized chromatin and a single central nucleolus; rare mitotic figures (except nMZL) | CD1+, CD20+, CD21+, CD45+, CD79a+, MHCII+, CD18intermediate |
T-zone lymphoma (TZL) | Usually multicentric Lymphadenopathy | Nodular, paracortical, progressing to diffuse | Small to intermediate- sized cells; moderate amount of pale cytoplasm; oval to elliptical nuclei with sharp, shallow indentations; nucleoli and mitotic figures are sparse | CD45–, CD3+, CD5+, CD21+, CD4+/–, CD8+/– |
Precursor lymphomaa | Multicentric and/or leukemia | Diffuse and/or leukemia | Intermediate-sized cells; round nuclei; scant Cytoplasm; high mitotic rate |
If T-cell: CD45+, CD34+/–, CD5+/–, CD3+/–, CD4+/–, CD8– If B-cell: CD45+, CD18+, CD34+/–, CD79a+, CD21+/–, CD20+/– |
Mantle cell lymphoma (MCL) | Splenic white pulp | Nodular/ follicular | Small to intermediate- sized cells; scant cytoplasm; round nuclei with dense chromatin, inconspicuous nucleoli; varied mitotic rate | CD20+, CD21+, CD45+, CD79a+, MHCII+ |
Follicular lymphoma | Lymphadenopathy, solitary or multiple | Nodular/ follicular | Mixed—mostly small cells with clear cytoplasm, pale chromatin, and inconspicuous nucleoli (centrocytes) with fewer large cells with dark blue cytoplasm, vesicular nuclei, and 1–3 nucleoli (centroblasts) | CD20+, CD21+, CD45+, CD79a+, MHCII+ |
Precursor lymphoma includes lymphoblastic B- or T-cell lymphomas and B- or T-cell acute leukemias.
Adapted with permission from Seelig DM, Avery AC, Ehrhart EJ, Linden MA. The comparative diagnostic features of canine and human lymphoma. Vet Sci. 2016;3: Epub ahead of print. https://doi.org/10.3390/vetsci3020011; and Burkhard MJ, Bienzle D. Making sense of lymphoma diagnostics in small animal patients. Vet Clin North Am Small Anim Pract. 2013;43:1331-1347.